@FiercePharma: Dutch researchers are comparing GSK's Advair Diskus with a rival device in a study funded by $GSK. Item | Follow @FiercePharma
> Daiichi Sankyo shares dropped after the drugmaker lowered its sales forecast for the year ending March 2012, predicting a decline of 3.9% on the stronger yen. Article
> Impax Laboratories ($IPXL) posted street-beating profits of $17.2 million on revenue of $119.8 million, an 11% year-over-year increase. Story
> Contract manufacturer Lonza saw revenue growth suffer during the third quarter, thanks to the strength of the Swiss franc and high raw materials prices. Item
> Lupus organizations are lobbying the U.K.'s National Institute for Health and Clinical Excellence for coverage on the new drug Benlysta from Human Genome Sciences and GlaxoSmithKline ($GSK). Release
> Environmental and parent groups are pushing Johnson & Johnson ($JNJ) to remove potentially harmful chemicals from U.S. versions of its baby shampoo as it has in some other markets. News
Biotech News
@FierceBiotech: PathoGenetix raises $7.5M in second closing of series B financing for rapid bacterial identification system. Story | Follow @FierceBiotech
@JohnCFierce: Exelixis has always had problems with study designs; source of issue with BMS. Fight the FDA, though? Shares tank. Item | Follow @JohnCFierce
@RyanMFierce: U.K. trial aims to test use of agents to make tricky brain tumors glow to aid surgical removal. Makes sense. Report | Follow @RyanMFierce
> Exelixis clashes with FDA over prostate cancer study, shares tank. Story
> NPS Pharma shares sink after cancers reported in patients on bowel drug. Report
> Report: Biotech VCs from Morgenthaler, ATV part ways with IT colleagues. Item
Biotech Research News
> Jackson Lab ready to start hiring for new genetics center. Item
> Caltech team designs a new and improved HIV antibody. Article
> Court ruling could derail ambitious stem cell program for synthetic blood. Report
> Investigators tout a new therapeutic approach to cardiovascular disease. News
Manufacturing News
> Ranking: Baxter, J&J lead green pharma companies. News
> Researchers tout big increase in heparin yield. Report
> KV Pharma, ex-CEO battle over recall responsibility. Item
> Closures a sign of Novartis minimizing production in Switzerland. Report
> Obama takes aim at drug shortages. News
And Finally... A significant number of colon cancers could be caused by a bacteria, a new study finds. Article